Indeed, high SIAH2 gene expression was associated with favorable relapse free survival (RFS) among breast cancer patients (Figure 5G) and, in particular, among patients lacking sufficient expression of ER and HER2 (including TNBCs) (Supplementary Figure 4C). Here, ESR1 is linked to breast carcinoma.